• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
    All News #Library

    Ningxia Taiyicin Biotech`s Fails EDQM inspection

    EMA

    Turbare Manufacturing’s Receives FDA Warning Letter

    FDA

    Rhyz Analytical’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to North American Custom Laboratories

    FDA

    Owen Bio’s Receives FDA Warning Letter

    FDA

    Wells Pharma of Houston’s Receives FDA Warning Letter

    FDA

    FDA Issues Form 483 to Fareva Amboise

    FDA

    FDA Issues Form 483 to Immacule Lifesciences

    FDA

    RNA Bio Pharma’s Receives FDA Warning Letter

    FDA

    Siddha Flower Essences’ Receives FDA Warning Letter

    FDA

    Cdymax Pharma’s Receives FDA Warning Letter

    FDA

    DermaRite Industries’ Receives FDA Warning Letter

    FDA

    Uriel Pharmacy’s Receives FDA Warning Letter

    FDA

    Verdure’s Receives FDA Warning Letter

    FDA

    Sinsin’s Receives FDA Warning Letter

    FDA

    Shoplet’s Receives FDA Warning Letter

    FDA

    World Perfumes’ Receives FDA Warning Letter

    FDA

    Save Rite Medical’s Receives FDA Warning Letter

    FDA

    Medical Mega’s Receives FDA Warning Letter

    FDA

    Cdymax`s Receives FDA Warning Letter

    FDA

    RNA Bio/Pharma`s Recieves FDA Warning Letter

    FDA

    FDA Issues Form 483 to Sanofi

    FDA

    Enforcement Report - Week of November 12, 2025

    FDA

    Miers Laboratories Receives FDA Warning Letter

    FDA

    Taizhou Kangping Medical Scienc Receives FDA Warning Letter

    FDA

    Apotex Receives FDA Warning Letter

    FDA

    Fresenius Kabi Issues Voluntary Nationwide Recall of Famotidine

    FDA

    FDA Issues Form 483 to Medispray Lab

    FDA

    FDA Issues Form 483 to Alvotech

    FDA

    FDA Issues Form 483 to Baxter Oncology

    FDA

    FDA Issues Form 483 to Alvotech Hf

    FDA

    FDA Issues Form 483 to Laurus Lab

    FDA

    Enforcement Report - Week of November 5, 2025

    FDA

    Scientific Protein Laboratories Receives FDA Warning Letter

    FDA

    Liebel-Flarsheim Company Receives FDA Warning Letter

    FDA

    Kath Khemicals Receives FDA Warning Letter

    FDA

    ICU Medical Issues Voluntary Nationwide Recall of 20 mEq NaCl Inj

    FDA

    FDA Issues Form 483 to Alembic Pharma

    FDA

    FDA Issues Form 483 to Zydus Lidescience

    FDA

    FDA Issues Form 483 to Corcord Biotech

    FDA

    Enforcement Report - Week of October 29, 2025

    FDA

    The Tranzonic Companies/Innocore Receives FDA Warning Letter

    FDA

    Miers Laboratories is on FDA Import Alert List

    FDA

    FDA Issues Form 483 to Dr. Reddy

    FDA

    Valpharma International`s Fails EDQM inspection

    EMA

    Melcare Biomedical Receives FDA Warning Letter

    FDA

    Guangxi Yulin Pharmaceutical Group Receives FDA Warning Letter

    FDA

    BRS Analytical Services Receives FDA Warning Letter

    FDA

    Acme United Corporation Receives FDA Warning Letter

    FDA

    Foshan Yiying Hygiene Products Co. Receives FDA Warning Letter

    FDA

    Allovate Therapeutics Receives FDA Warning Letter

    FDA

    Health And Natural Beauty Corp. Receives FDA Warning Letter

    FDA

    Indeus Life Sciences Private Limited`s Fails EDQM inspection

    EMA

    Health Canada Issues Recalls of Sandoz`s Lisinopril tablet

    HEALTH CANADA

    Prothya Biosolutions Netherlands B.V.`s Fails EDQM inspection

    EMA

    Enforcement Report - Week of October 8, 2025

    FDA

    Creative Essences Receives FDA Warning Letter

    FDA

    Naturich Cosmetique Labs Receives FDA Warning Letter

    FDA

    Dixon Receives FDA Warning Letter

    FDA

    New Life Medical Services Receives FDA Warning Letter

    FDA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.